• 1
    Sebbag, M., Simon, M., Vincent, C., Masson-Bessiere, C., Girbal, E., Durieux, J. J. and Serre, G., The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 1995. 95: 26722679.
  • 2
    Schellekens, G. A., de Jong, B. A., van den Hoogen, F. H., van de Putte, L. B. and van Venrooij, W. J., Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 1998. 101: 273281.
  • 3
    Rantapaa-Dahlqvist, S., de Jong, B. A., Berglin, E., Hallmans, G., Wadell, G., Stenlund, H., Sundin, U. and van Venrooij, W. J., Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003. 48: 27412749.
  • 4
    Vossenaar, E. R., Zendman, A. J., van Venrooij, W. J. and Pruijn, G. J., PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003. 25: 11061118.
  • 5
    Vossenaar, E. R., Radstake, T. R., van der Heijden, A., van Mansum, M. A., Dieteren, C., de Rooij, D. J., Barrera, P., Zendman, A. J. and van Venrooij, W. J., Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann. Rheum. Dis. 2004. 63: 373381.
  • 6
    Vossenaar, E. R., Despres, N., Lapointe, E., van der Heijden, A., Lora, M., Senshu, T., van Venrooij, W. J. and Menard, H. A., Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res. Ther. 2004. 6: R142150.
  • 7
    Masson-Bessiere, C., Sebbag, M., Girbal-Neuhauser, E., Nogueira, L., Vincent, C., Senshu, T. and Serre, G., The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J. Immunol. 2001. 166: 41774184.
  • 8
    Vossenaar, E. R., van Boekel, M. A., van Venrooij, W. J., Lopez-Hoyoz, M., Merino, J., Merino, R. and Joosten, L. A., Absence of citrulline-specific autoantibodies in animal models of autoimmunity. Arthritis Rheum. 2004. 50: 23702372.
  • 9
    Burkhardt, H., Koller, T., Engström, A., Nandakumar, K. S., Turnay, J., Kraetsch, H. G., Kalden, J. R. and Holmdahl, R., Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. Arthritis Rheum. 2002. 46: 23392348.
  • 10
    Nandakumar, K. S., Svensson, L. and Holmdahl, R., Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am. J. Pathol. 2003. 163: 18271837.
  • 11
    Choi, E. K., Gatenby, P. A., McGill, N. W., Bateman, J. F., Cole, W. G. and York, J. R., Autoantibodies to type II collagen: occurrence in rheumatoid arthritis, other arthritides, autoimmuneconnective tissue diseases, and chronic inflammatory syndromes. Ann. Rheum. Dis. 1988. 47: 313322.
  • 12
    Cook, A. D., Rowley, M. J., Mackay, I. R., Gough, A. and Emery, P., Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression. Arthritis Rheum. 1996. 39: 17201727.
  • 13
    Schulte, S., Unger, C., Mo, J. A., Wendler, O., Bauer, E., Frischholz, S., von der Mark, K., Kalden, J. R., Holmdahl, R. and Burkhardt, H., Arthritis-related B cell epitopes in collagen II are conformation-dependent and sterically privileged in accessible sites of cartilage collagen fibrils. J. Biol. Chem. 1998. 273: 15511561.
  • 14
    Kraetsch, H. G., Unger, C., Wernhoff, P., Schneider, C., Kalden, J. R., Holmdahl, R. and Burkhardt, H., Cartilage-specific autoimmunity in rheumatoid arthritis: characterization of a triple helical B cell epitope in the integrin-binding-domain of collagen type II. Eur. J. Immunol. 2001. 31: 16661673.
  • 15
    Backlund, J., Carlsen, S., Hoger, T., Holm, B., Fugger, L., Kihlberg, J., Burkhardt, H. and Holmdahl, R., Predominant selection of T cells specific for glycosylated collagen type II peptide (263–270) in humanized transgenic mice and in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 2002. 99: 99609965.
  • 16
    Dzhambazov, B., Holmdahl, M., Yamada, H., Lu, S., Vestberg, M., Holm, B., Johnell, O., Kihlberg, J. and Holmdahl, R., The major T cell epitope on type II collagen is glycosylated in normal cartilage but modified by arthritis in both rats and humans. Eur. J. Immunol. 2005. 35: 357366.
  • 17
    Fleckenstein, B., Molberg, O., Qiao, S. W., Schmid, D. G., von der Mulbe, F., Elgstoen, K., Jung, G. and Sollid, L. M., Gliadin T cell epitope selection by tissue transglutaminase in celiac disease: Role of enzyme specificity and pH influence on the transamidation vs. deamidation reactions. J. Biol. Chem. 2002. 277: 3410934116.
  • 18
    Molberg, O., Kett, K., Scott, H., Thorsby, E., Sollid, L. M. and Lundin, K. E., Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand. J. Immunol. 1997. 46: 103109.
  • 19
    Sollid, L. M., Markussen, G., Ek, J., Gjerde, H., Vartdal, F. and Thorsby, E., Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J. Exp. Med. 1989. 169: 345350.
  • 20
    Andersson, E. C., Hansen, B. E., Jacobsen, H., Madsen, L. S., Andersen, C. B., Engberg, J., Rothbard, J. B., McDevitt, G. S., Malmström, V., Holmdahl, R. et al., Definition of MHC and T cell receptor contacts in the HLA-DR4 restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc. Natl. Acad. Sci. USA 1998. 95: 75747569.
  • 21
    Mediwake, R., Isenberg, D. A., Schellekens, G. A. and van Venrooij, W. J., Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann. Rheum. Dis. 2001. 60: 6768.
  • 22
    Avcin, T., Cimaz, R., Falcini, F., Zulian, F., Martini, G., Simonini, G., Porenta-Besic, V., Cecchini, G., Borghi, M. O. and Meroni, P. L., Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann. Rheum. Dis. 2002. 61: 608611.
  • 23
    Soderlin, M. K., Kastbom, A., Kautiainen, H., Leirisalo-Repo, M., Strandberg, G. and Skogh, T., Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity. Scand. J. Rheumatol. 2004. 33: 185188.
  • 24
    Arnett, F. C., Edworthy, S. M., Bloch, D. A., McShane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S. et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988. 31: 315324.
  • 25
    Hochberg, M. C., Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997. 40: 1725.
  • 26
    Tarcsa, E., Marekov, L. N., Mei, G., Melino, G., Lee, S. C. and Steinert, P. M., Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J. Biol. Chem. 1996. 271: 3070930716.
  • 27
    Grab, B., Miles, A. J., Furcht, L. T. and Fields, G. B., Promotion of fibroblast adhesion by triple-helical peptide models of type I collagen-derived sequences. J. Biol. Chem. 1996. 271: 1223412240.